SCOPUS 정보 검색 플랫폼

Leukemia

Volumn 16, Issue 9, 2002, Pages 1835-1837

Clinical activity of arsenic trioxide for the treatment of multiple myeloma

(9) Munshi, N C a Tricot, G a Desikan, R b Badros, A c Zangari, M a Toor, A d Morris, C a Anaissie, E a Barlogie, B a

a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (United States)

b ST VINCENT S COMPREHENSIVE CANCER CENTER (United States)

c UNIVERSITY OF MARYLAND MEDICAL CENTER (United States)

d LOYOLA UNIVERSITY CHICAGO (United States)

Author keywords

Antiangiogenesis; Apoptosis; Arsenic trioxide; Multiple myeloma

Indexed keywords

ARSENIC TRIOXIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; THALIDOMIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTEREMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DEEP VEIN THROMBOSIS; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; INFECTIOUS COMPLICATION; INFECTIOUS PNEUMONIA; MULTIPLE MYELOMA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SALVAGE THERAPY; SEPTICEMIA;

EID: 0036739745 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2402599 Document Type: Article

Times cited : (135)

References (17)

1
- 0033928972
- The biology of multiple myeloma
- (2000) J. Cancer Res. Clin. Oncol , vol.126 , pp. 441-447
- Drach, J.¹ Kaufmann, H.² Urbauer, E.³ Schreiber, S.⁴ Ackermann, J.⁵ Huber, H.⁶

2
- 0001646474
- Multiple myeloma, macroglobulinemia, and the monoclonal gammopathies
- (1999) Curr. Pract. Med , vol.2 , pp. 1131-1137
- Kyle, R.A.¹

3
- 0033400218
- Prognostic factors in multiple myeloma
- (1999) Hematol. Oncol. Clin. N. Am , vol.13 , pp. 1295-1314
- Rajkumar, S.V.¹ Greipp, P.R.²

4
- 0000210796
- Thirty-two cases of treating acute promyelocytic leukemia by Ailing-1 (cancer-cure-1) therapy combined with syndrome differentiation treatment of traditional chinese medicine
- (1992) Chin. J. Comb. Trad. Chin. Med. West Med , vol.12 , pp. 170-171
- Sun, H.-D.¹ Ma, L.² Hu, C.-X.³ Zhang, T.-D.⁴

5
- 0033570955
- Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
- (1999) Blood , vol.94 , pp. 3315-3324
- Niu, C.¹ Yan, H.² Yu, T.³ Sun, H.-P.⁴ Liu, J.-X.⁵ Li, X.-S.⁶ Wu, W.⁷ Zhang, F.-Q.⁸ Chen, Y.⁹ Zhou, L.¹⁰ Li, J.-M.¹¹ Zeng, X.-Y.¹² Ou Yang, R.-R.¹³ Yuan, M.-M.¹⁴ Ren, M.-Y.¹⁵ Gu, F.-Y.¹⁶ Cao, Q.¹⁷ Gu, B.-W.¹⁸ Su, X.-Y.¹⁹ Chen, G.-Q.²⁰ more..

6
- 0030610687
- 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
- (1997) Blood , vol.89 , pp. 3354-3360
- Shen, Z.-X.¹ Chen, G.-Q.² Ni, J.-H.³ Li, X.-S.⁴ Xiong, S.-M.⁵ Qiu, Q.-Y.⁶ Zhu, J.⁷ Tang, W.⁸ Sun, G.-L.⁹ Yang, K.-Q.¹⁰ Chen, Y.¹¹ Zhou, L.¹² Fang, Z.-W.¹³ Wang, Y.-T.¹⁴ Ma, J.¹⁵ Zhang, P.¹⁶ Zhang, T.-D.¹⁷ Chen, S.-J.¹⁸ Chen, Z.¹⁹ Wang, Z.-Y.²⁰ more..

7
- 0033526358
- Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations
- (1999) J. Natl. Cancer Inst , vol.91 , pp. 772-778
- Zhu, X.-H.¹ Shen, Y.-L.² Jing, Y.-K.³ Cai, X.⁴ Jia, P.-M.⁵ Huang, Y.⁶ Tang, W.⁷ Shi, G.-Y.⁸ Sun, Y.-P.⁹ Dai, J.¹⁰ Wang, Z.-Y.¹¹ Chen, S.-J.¹² Zhang, T.-D.¹³ Waxman, S.¹⁴ Chen, Z.¹⁵ Chen, G.-Q.¹⁶

8
- 0033568238
- Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
- (1999) Blood , vol.94 , pp. 2102-2111
- Jing, Y.¹ Dai, J.² Chalmers-Redman, R.M.³ Tatton, W.G.⁴ Waxman, S.⁵

9
- 0034212785
- Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis
- (2000) Cancer Res , vol.60 , pp. 3065-3071
- Park, W.H.¹ Seol, J.G.² Kim, E.S.³ Hyun, J.M.⁴ Jung, C.W.⁵ Lee, C.C.⁶ Kim, B.K.⁷ Lee, Y.Y.⁸

10
- 0033105268
- Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients
- (1999) Cancer Res , vol.59 , pp. 1041-1048
- Rousselot, P.¹ Labaume, S.² Marolleau, J.-P.³ Larghero, J.⁴ Noguera, M.-H.⁵ Brouet, J.-C.⁶ Fermand, J.-P.⁷

11
- 8944220233
- Intergroupe Français du Myélome. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
- (1996) N. Engl. J. Med , vol.335 , pp. 91-97
- Attal, M.¹ Harousseau, J.-L.² Stoppa, A.-M.³ Sotto, J.-J.⁴ Fuzibet, J.-G.⁵ Rossi, J.-F.⁶ Casassus, P.⁷ Maisonneuve, H.⁸ Facon, T.⁹ Ifrah, N.¹⁰ Payen, C.¹¹ Bataille, R.¹²

12
- 0026733455
- Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
- (1992) Blood , vol.80 , pp. 1666-1672
- Jagannath, S.¹ Vesole, D.H.² Glenn, L.³ Crowley, J.⁴ Barlogie, B.⁵

13
- 0031803968
- Long-term follow-up after high-dose therapy for high-risk multiple myeloma
- (1998) Bone Marrow Transplant , vol.21 , pp. 1101-1107
- Barlogie, B.¹ Jagannath, S.² Naucke, S.³ Mattox, S.⁴ Bracy, D.⁵ Crowley, J.⁶ Tricot, G.⁷ Alexanian, R.⁸

14
- 18544409610
- Results of high-dose therapy for 1000 patients with multiple myeloma: Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
- (2000) Blood , vol.95 , pp. 4008-4010
- Desikan, R.¹ Barlogie, B.² Sawyer, J.³ Ayers, D.⁴ Tricot, G.⁵ Badros, A.⁶ Zangari, M.⁷ Munshi, N.C.⁸ Anaissie, E.⁹ Spoon, D.¹⁰ Siegel, D.¹¹ Jagannath, S.¹² Vesole, D.¹³ Epstein, J.¹⁴ Shaughnessy, J.¹⁵ Fassas, A.¹⁶ Lim, S.¹⁷ Roberson, P.¹⁸ Crowley, J.¹⁹

15
- 0035030143
- Arsenic trioxide: An emerging therapy for multiple myeloma
- (2001) Oncologist , vol.6 , pp. 17-21
- Munshi, N.C.¹

16
- 0035884639
- United states multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
- (2001) J. Clin. Oncol , vol.19 , pp. 3852-3860
- Soignet, S.L.¹ Frankel, S.R.² Douer, D.³ Tallman, M.S.⁴ Kantarjian, H.⁵ Calleja, E.⁶ Stone, R.M.⁷ Kalaycio, M.⁸ Scheinberg, D.A.⁹ Steinherz, P.¹⁰ Sievers, E.L.¹¹ Coutré, S.¹² Dahlberg, S.¹³ Ellison, R.¹⁴ Warrell, R.P.¹⁵

17
- 0001748248
- 3): A dose-ranging and clinical pharmacologic study in patients with advanced hematologic cancers
- (Abstr. 3462)
- (2000) Cancer Res , vol.41 , pp. 543
- Soignet, S.L.¹ Novick, S.² Bienvenu, B.³ Chanel, S.⁴ Ho, R.⁵ Spriggs, D.⁶ Ellison, R.⁷ Warrell, R.P.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.